Smooth Switch to the EAEU Marketing Authorization for Medicinal Products

Webinar: Smooth Switch to the EAEU Marketing Authorization for Medicinal Products

The webinar will highlight the practical tips and guide you through the crucial steps of marketing authorization upgrade to the Eurasian Economic Union (EAEU) one, ultimately leading you towards a successful submission strategy development.

As of now, all national medicinal product marketing authorizations are valid in EAEU until their expiry date. However, the mentioned marketing authorizations must be revalidated according to the EAEU regulations until December 31st, 2025.

You will learn:

What do you need to prepare and implement now to timely and successfully transition to the EAEU marketing authorization?

  1. What are the main points you need to consider when going into the upgrade procedure?
  2. What do you need to know about EAEU GMP certification?
  3. What are the readability user testing requirements?
  4. Timelines

Preparing for a marketing authorization upgrade?

Create a successful submission strategy development. Explore your options in an informal chat.

Who Should Attend?

Professionals from the following fields:

  • Regulatory Managers
  • Regulatory Strategy Managers
  • RA Partnerships Operations Manager
  • QA Managers supporting RA
  • RA Healthcare Compliance Managers

Duration: 45 min.

Speaker: Regulatory Affairs Project Manager CIS, Nargiz Asgarova, who will share her expertise regarding drug registration in the Eurasian Economic Union.

Nargiz Asgarova

Nargiz Asgarova

Regulatory Affairs Project Manager CIS

Other content that might interest you:

Affiliate Based Outsourcing Model for Regulatory Affairs.

Affiliate Based Outsourcing Model for Regulatory Affairs.

 Affiliate based Outsourcing Model for Regulatory Affairs works as a replacement or an extension of the company’s internal and local RA resources. Many challenges come up from managing your RA activities as sometimes their processes are not harmonized across different...

read more
Regulatory Outsourcing in the CEE Region

Regulatory Outsourcing in the CEE Region

In this informative session we decode the intricate landscape of regulatory affairs outsourcing in the CEE region and provide practical, implementable strategies to optimize and maximize your operations and outsourcing strategies.Let’s discuss how we can streamline...

read more
Regulatory Framework of Drugs in MENA: Insights

Regulatory Framework of Drugs in MENA: Insights

In this webinar, our experts discuss regulatory affairs of medicinal products. Two aspects that have recently gained increasing importance among the various stakeholders, namely the eCTD implementation across the region and the serialization and barcoding requirements...

read more
Whitepaper: Computerised System Validation & Pharmacovigilance

Whitepaper: Computerised System Validation & Pharmacovigilance

Gain insights into optimised CSV solutions, and their role in effective risk management. Key Highlights: In-depth CSV risk management strategies Ensuring data integrity and reliability in PV systems Case study on validating a cloud-based safety database At Biomapas,...

Breaking silos across Medical Information & Pharmacovigilance

Breaking silos across Medical Information & Pharmacovigilance

Discover solutions for effective PV & MI data management, including handling Adverse Events, Product Quality Complaints, and MI inquiries. Our experts will walk you through real-life examples and hands-on solutions. Looking to improve your PV & MI data...

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information